Efeitos de dose de nitrogênio, fósforo e potássio sobre os componentes da produção e a qualidade de bananas 'Prata Anã' no distrito agroindustrial de Jaíba

Com o objetivo de verificar os efeitos da adubação nitrogenada, fosfatada e potássica sobre os componentes da produção e a qualidade de bananas 'Prata Anã', no Distrito Agroindustrial de Jaíba, em Matias Cardoso-MG, foi conduzido um experimento com dez tratamentos constituídos pela combinação de doses (g/touceira) de N, P e K de acordo com uma matriz baconiana, sendo 1: 250-45-700, 2: 250-25-700, 3: 250-70-700, 4: 250-100-700, 5: 250-45-300, 6: 250-45-500, 7: 250-45-1000, 8: 150-45-700, 9: 400-45-700, 10: 600-45-700. O tratamento um é o de referência, correspondendo às doses adotadas pelos bananicultores da região. O delineamento foi de blocos ao acaso com quatro repetições. Avaliou-se a produção do primeiro ciclo. Os cachos foram colhidos, despencados e avaliados quanto ao número de pencas, número de frutos e massa do cacho, massa média das pencas e massa média, diâmetro e comprimentos total e comercial do fruto. Os resultados indicaram que as doses de nitrogênio ou fósforo utilizadas pelos produtores de banana do Distrito Agroindustrial de Jaíba podem ser reduzidas para 150 ou 25 g/touceira, respectivamente, sem prejuízo para a produção e qualidade dos frutos. Por outro lado, as doses de potássio até 1000 g/touceira, parceladas semanalmente, proporcionaram aumentos significativos na massa, comprimento total e comercial do fruto.

Caracterização fenológica e requerimentos térmicos de variedades de uvas sem sementes no Vale do São Francisco

O comportamento fenológico e requerimentos térmicos de variedades de uvas sem sementes foram estudados nas condições do Vale do São Francisco durante os anos de 2001-2002, em seis diferentes datas de poda (12/2000, 04/2001, 06/2001, 10/2001, 01-02/2002 e 04/2002). O experimento foi realizado no Campo Experimental de Bebedouro, em Petrolina-PE. As variedades utilizadas foram Superior Seedless (Festival), Thompson Seedless, Catalunha, Perlette e Marroo Seedless, enxertadas sobre porta-enxerto IAC 572 ('Jales'). Avaliou-se a duração em dias dos estádios fenológicos, gemas dormentes (data de poda) a gemas inchadas (1), gemas inchadas a início de brotação (2), início de brotação a 5-6 folhas separadas (3), 5-6 folhas separadas a início de floração (4), início de floração à plena-floração (5), plena-floração a "chumbinho" (6), "chumbinho" à "ervilha" (7), "ervilha" a ½ baga (8), ½ baga a início de maturação (9) e início de maturação à maturação plena (10). Os requerimentos térmicos foram obtidos em termos de graus-dia (GD) necessários para atingir cada fase fenológica a partir da poda. O ciclo fenológico médio variou de 89 dias e 1.315 GD na variedade Superior Seedless a 105 dias e 1.514 GD na variedade Perlette, destacando-se as variedades Superior Seedless e Marroo Seedless como precoces e as demais com ciclo intermediário. Os períodos compreendidos entre o início e final da maturação, ½ baga a início de maturação e 5 a 6 folhas separadas a início de floração apresentaram a maior duração entre todos os subperíodos em todas as variedades.

Viabilidade do pólen e desenvolvimento do tubo polínico em macieira (Malus spp.)

No presente trabalho, estudaram-se características associadas à germinação in vitro e ao desenvolvimento in vivo do tubo polínico em seis variedades-copa e de porta-enxertos de macieira como subsídios para o estabelecimento de programas de melhoramento genético. Utilizou-se de pólen de seis cultivares de macieira inoculado em meio de cultura com ágar (10 g.L-1) em água destilada, combinados com concentrações de sacarose (0; 10; 20; 30; 40 e 50%) e ácido bórico (0 e 40 mg.L-1). Para o estudo do desenvolvimento do tubo polínico, realizou-se coleta das flores em quatro períodos (6; 12; 24 e 48 horas após as polinizações) em M9 x Marubakaido e a autofecundação em M9, sendo os tubos polínicos analisados em coloração de azul de anilina acidificada/carmim acético e em fluorescência. A sacarose, em concentrações entre 15% a 25%, pode ser empregada com sucesso para a germinação in vitro de grãos de pólen da macieira. O ácido bórico não teve efeito positivo para esta característica. Na ausência do ácido bórico e na presença de 15% de sacarose, observaram-se os maiores percentuais de germinação: Fuji (51,1%), Imperatriz (31,7%), M.9 (20,8%), Catarina (19,2%), Gala (13,7%) e Marubakaido (6,1%). Quanto ao desenvolvimento do tubo polínico, com 12 horas da polinização, iniciou-se a germinação no pólen, no estigma, no cruzamento M.9 x Marubakaido, e após 24 horas da polinização observou-se 83% de germinação. As técnicas de coloração com azul de anilina acidificada com carmim acético e de visualização em fluorescência foram eficientes na visualização e coloração dos grãos de pólen e do desenvolvimento dos tubos polínicos.

Characterization of fortuitously discovered focal liver lesions: additional information provided by shearwave elastography.

OBJECTIVES: To prospectively assess the stiffness of incidentally discovered focal liver lesions (FLL) with no history of chronic liver disease or extrahepatic cancer using shearwave elastography (SWE). METHODS: Between June 2011 and May 2012, all FLL fortuitously discovered on ultrasound examination were prospectively included. For each lesion, stiffness was measured (kPa). Characterization of the lesion relied on magnetic resonance imaging (MRI) and/or contrast-enhanced ultrasound, or biopsy. Tumour stiffness was analysed using ANOVA and non-parametric Mann-Whitney tests. RESULTS: 105 lesions were successfully evaluated in 73 patients (61 women, 84%) with a mean age of 44.8 (range: 20‒75). The mean stiffness was 33.3 ± 12.7 kPa for the 60 focal nodular hyperplasia (FNH), 19.7 ± 9.8 k Pa for the 17 hepatocellular adenomas (HCA), 17.1 ± 7 kPa for the 20 haemangiomas, 11.3 ± 4.3 kPa for the five focal fatty sparing, 34.1 ± 7.3 kPa for the two cholangiocarcinomas, and 19.6 kPa for one hepatocellular carcinoma (p < 0.0001). There was no difference between the benign and the malignant groups (p = 0.64). FNHs were significantly stiffer than HCAs (p < 0.0001). Telangiectatic/inflammatory HCAs were significantly stiffer than the steatotic HCAs (p = 0.014). The area under the ROC curve (AUROC) for differentiating FNH from other lesions was 0.86 ± 0.04. CONCLUSION: SWE may provide additional information for the characterization of FFL, and may help in differentiating FNH from HCAs, and in subtyping HCAs. KEY POINTS: ? SWE might be helpful for the characterization of solid focal liver lesions ? SWE cannot differentiate benign from malignant liver lesions ? FNHs are significantly stiffer than other benign lesions ? Telangiectatic/inflammatory HCA are significantly stiffer than steatotic ones.

MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial.

PURPOSE: Rechallenge with temozolomide (TMZ) at first progression of glioblastoma after temozolomide chemoradiotherapy (TMZ/RT→TMZ) has been studied in retrospective and single-arm prospective studies, applying temozolomide continuously or using 7/14 or 21/28 days schedules. The DIRECTOR trial sought to show superiority of the 7/14 regimen. EXPERIMENTAL DESIGN: Patients with glioblastoma at first progression after TMZ/RT→TMZ and at least two maintenance temozolomide cycles were randomized to Arm A [one week on (120 mg/m(2) per day)/one week off] or Arm B [3 weeks on (80 mg/m(2) per day)/one week off]. The primary endpoint was median time-to-treatment failure (TTF) defined as progression, premature temozolomide discontinuation for toxicity, or death from any cause. O(6)-methylguanine DNA methyltransferase (MGMT) promoter methylation was prospectively assessed by methylation-specific PCR. RESULTS: Because of withdrawal of support, the trial was prematurely closed to accrual after 105 patients. There was a similar outcome in both arms for median TTF [A: 1.8 months; 95% confidence intervals (CI), 1.8-3.2 vs. B: 2.0 months; 95% CI, 1.8-3.5] and overall survival [A: 9.8 months (95% CI, 6.7-13.0) vs. B: 10.6 months (95% CI, 8.1-11.6)]. Median TTF in patients with MGMT-methylated tumors was 3.2 months (95% CI, 1.8-7.4) versus 1.8 months (95% CI, 1.8-2) in MGMT-unmethylated glioblastoma. Progression-free survival rates at 6 months (PFS-6) were 39.7% with versus 6.9% without MGMT promoter methylation. CONCLUSIONS: Temozolomide rechallenge is a treatment option for MGMT promoter-methylated recurrent glioblastoma. Alternative strategies need to be considered for patients with progressive glioblastoma without MGMT promoter methylation.

Five-year outcome of catheter ablation of persistent atrial fibrillation using termination of atrial fibrillation as a procedural endpoint.

BACKGROUND: This study aimed to determine 5-year efficacy of catheter ablation for persistent atrial fibrillation (AF) using AF termination as a procedural end point. METHODS AND RESULTS: One hundred fifty patients (57±10 years) underwent persistent AF ablation using a stepwise ablation approach (pulmonary vein isolation, electrogram-guided, and linear ablation) with the desired procedural end point being AF termination. Repeat ablation was performed for recurrent AF or atrial tachycardia. AF was terminated by ablation in 120 patients (80%). Arrhythmia-free survival rates after a single procedure were 35.3%±3.9%, 28.0%±3.7%, and 16.8%±3.2% at 1, 2, and 5 years, respectively. Arrhythmia-free survival rates after the last procedure (mean 2.1±1.0 procedures) were 89.7%±2.5%, 79.8%±3.4%, and 62.9%±4.5%, at 1, 2, and 5 years, respectively. During a median follow-up of 58 (interquartile range, 43-73) months after the last ablation procedure, 97 of 150 (64.7%) patients remained in sinus rhythm without antiarrhythmic drugs. Another 14 (9.3%) patients maintained sinus rhythm after reinitiation of antiarrhythmic drugs, and an additional 15 (10.0%) patients regressed to paroxysmal recurrences only. Failure to terminate AF during the index procedure (hazard ratio 3.831; 95% confidence interval, 2.070-7.143; P<0.001), left atrial diameter ≥50 mm (hazard ratio 2.083; 95% confidence interval, 1.078-4.016; P=0.03), continuous AF duration ≥18 months (hazard ratio 1.984; 95% confidence interval, 1.024-3.846; P<0.04), and structural heart disease (hazard ratio 1.874; 95% confidence interval, 1.037-3.388; P=0.04) predicted arrhythmia recurrence. CONCLUSIONS: In patients with persistent AF, an ablation strategy aiming at AF termination is associated with freedom from arrhythmia recurrence in the majority of patients over a 5-year follow-up period. Procedural AF nontermination and specific baseline factors predict long-term outcome after ablation.

Qualidade de mangas cv. Palmer após armazenamento sob baixas temperaturas

Este trabalho objetivou avaliar a qualidade de mangas 'Palmer' previamente armazenadas em baixas temperaturas, após sua transferência para a condição de ambiente. Frutos colhidos no estádio de maturação fisiológica foram cuidadosamente transportados, selecionados, padronizados quanto à coloração, tamanho e ausência de injúrias, e tratados com fungicida, antes de serem armazenados a 2ºC (75,7% UR), 5ºC (73,8% UR) e 12°C (82% UR), por 7; 14 e 21 dias. Ao final de cada período, os frutos foram transferidos para temperatura ambiente (22,9°C; 62,3% UR), onde foram mantidos por 1; 3; 5 e 7 dias, simulando o período de comercialização, e avaliados quanto à ocorrência de injúrias e podridões, coloração da casca e polpa, firmeza da polpa, teores de sólidos solúveis, acidez titulável e de ácido ascórbico, além da atividade das enzimas peroxidase, polifenoloxidase e fenilalanina amônia-liase. Os resultados indicaram que as mangas 'Palmer' podem ser conservadas a 12ºC por 21 dias, sem prejuízos ao amadurecimento, porém com limitações devido à ocorrência de podridões. O armazenamento a 2ºC e a 5ºC foi limitado pela ocorrência de injúrias na casca, porém na temperatura de 2ºC estes sintomas foram mais severos e comprometeram o desenvolvimento da coloração característica da casca. Entretanto, o amadurecimento da polpa destes frutos não foi prejudicado, mas este processo ocorreu com menor intensidade que nas mangas mantidas a 12ºC.

Nutrição mineral e produção de abacaxizeiro 'Pérola', em função das relações K/N na adubação

A adubação do abacaxizeiro deve contemplar a reposição das quantidades de N e K absorvidas pela planta e exportadas pelos frutos e mudas, e o estabelecimento de relações adequadas entre as doses destes nutrientes. Este trabalho objetivou avaliar o efeito de diferentes relações K/N na adubação sobre a nutrição mineral e a produção de abacaxizeiro 'Pérola', em solos de Tabuleiros Costeiros da Paraíba. O experimento foi conduzido em delineamento experimental em blocos casualizados com 13 tratamentos e três repetições. Os tratamentos resultaram da combinação de quatro relações K/N (0,85:1; 1:1; 2:1 e 3:1), duas doses de N (7,2 e 10,8 g planta-1), quatro tratamentos adicionais (relação K/N de 2:1 na maior dose de N, variando-se a fonte, o parcelamento, a época e a forma de aplicação das doses de N e K) e uma testemunha absoluta (sem adubação). O aumento das relações K/N eleva o peso da folha 'D', os teores de K e os valores das relações K/N e K/Mg; reduz os teores de N e não afeta os teores de P, Ca e a relação K/Ca. O aumento das relações K/N não influencia no peso médio, na produtividade e no percentual de frutos das classes I, II e III. A utilização de sulfato de K, o parcelamento das doses de N e K, na forma de KCl, em cinco aplicações, e a aplicação de metade das doses de N e K via foliar na relação 2:1 aumentam o peso da folha 'D', o teor foliar de N e os valores de peso médio, produtividade e percentual de frutos da classe II.

Periodontal health and esthetic results in impacted teeth exposed by apically positioned flap technique

Objectives: This study evaluates the periodontal health status and the esthetic results of teeth subjected to orthodontic traction, after their exposure by an apically positioned flap. Study design: Fifteen patients were included in the study, ages between 11 and 28 years old. The fenestrated teeth and their homologous contralateral normally erupted teeth, used as control, were evaluated. Results: Statistically significant differences were found in the position of the gingival margin (p = 0.005), with an average distance between cemento-enamel junction (CEJ) and gingival margin of 2.47 mm (SD 1.19) in control teeth and of 1 mm (SD 1.31) in the operated teeth, and in the depth of palatal probing (p = 0.031), with 2.1 mm (SD 0.9) for the experimental teeth and 1.7 mm (SD 0.8) for the control teeth. The gingival index, the bleeding during probing and the probing depth did not show statistically significant differences. The patient"s subjective esthetic evaluation was more favorable for the control teeth in most of the cases. Conclusions: The surgical approach for the impacted teeth by means of the apically positioned flap resulted to be a predictable technique allowing the maintenance of the periodontal health on a long-term basis.

Characterization of the chemical composition of the essential oils from Annona emarginata (Schltdl.) H. Rainer 'terra-fria' and Annona squamosa L.

The objective of this study was to characterize the chemical composition of the essential oil from the leaves of Annona emarginata (Schltdl.) H. Rainer 'terra-fria' and Annona squamosa L. The species were grown in a greenhouse for 18 months, which nutrient solution was applied weekly; the plants were then harvested and the leaves dried to extract the essential oil. The essential oil was analyzed by gas chromatography and mass spectrometry to study its chemical profiles. Eleven substances were found in the essential oil of A. emarginata, primarily (E)-caryophyllene (29.29%), (Z)-caryophyllene (16.86%), γ-muurolene (7.54%), α-pinene (13.86%), and tricyclene (10.04%). Ten substances were detected in the oil from A. squamosa, primarily (E)-caryophyllene (28.71%), (Z)-caryophyllene (14.46%), α-humulene (4.41%), camphene (18.10%), α-pinene (7.37%), β-pinene (8.71%), and longifolene (5.64%). Six substances were common to both species: (E)-caryophyllene, (Z)-caryophyllene, α-humulene, camphene, α-pinene, and β-pinene.

Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data.

BACKGROUND: Artemisinin-resistant Plasmodium falciparum has emerged in the Greater Mekong sub-region and poses a major global public health threat. Slow parasite clearance is a key clinical manifestation of reduced susceptibility to artemisinin. This study was designed to establish the baseline values for clearance in patients from Sub-Saharan African countries with uncomplicated malaria treated with artemisinin-based combination therapies (ACTs). METHODS: A literature review in PubMed was conducted in March 2013 to identify all prospective clinical trials (uncontrolled trials, controlled trials and randomized controlled trials), including ACTs conducted in Sub-Saharan Africa, between 1960 and 2012. Individual patient data from these studies were shared with the WorldWide Antimalarial Resistance Network (WWARN) and pooled using an a priori statistical analytical plan. Factors affecting early parasitological response were investigated using logistic regression with study sites fitted as a random effect. The risk of bias in included studies was evaluated based on study design, methodology and missing data. RESULTS: In total, 29,493 patients from 84 clinical trials were included in the analysis, treated with artemether-lumefantrine (n = 13,664), artesunate-amodiaquine (n = 11,337) and dihydroartemisinin-piperaquine (n = 4,492). The overall parasite clearance rate was rapid. The parasite positivity rate (PPR) decreased from 59.7 % (95 % CI: 54.5-64.9) on day 1 to 6.7 % (95 % CI: 4.8-8.7) on day 2 and 0.9 % (95 % CI: 0.5-1.2) on day 3. The 95th percentile of observed day 3 PPR was 5.3 %. Independent risk factors predictive of day 3 positivity were: high baseline parasitaemia (adjusted odds ratio (AOR) = 1.16 (95 % CI: 1.08-1.25); per 2-fold increase in parasite density, P <0.001); fever (>37.5 °C) (AOR = 1.50 (95 % CI: 1.06-2.13), P = 0.022); severe anaemia (AOR = 2.04 (95 % CI: 1.21-3.44), P = 0.008); areas of low/moderate transmission setting (AOR = 2.71 (95 % CI: 1.38-5.36), P = 0.004); and treatment with the loose formulation of artesunate-amodiaquine (AOR = 2.27 (95 % CI: 1.14-4.51), P = 0.020, compared to dihydroartemisinin-piperaquine). CONCLUSIONS: The three ACTs assessed in this analysis continue to achieve rapid early parasitological clearance across the sites assessed in Sub-Saharan Africa. A threshold of 5 % day 3 parasite positivity from a minimum sample size of 50 patients provides a more sensitive benchmark in Sub-Saharan Africa compared to the current recommended threshold of 10 % to trigger further investigation of artemisinin susceptibility.

Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism.

In cancer patients treated for venous thromboembolism (VTE), including deep-vein thrombosis (DVT) and pulmonary embolism (PE), analyzing mortality associated with recurrent VTE or major bleeding is needed to determine the optimal duration of anticoagulation.This was a cohort study using the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) Registry database to compare rates of fatal recurrent PE and fatal bleeding in cancer patients receiving anticoagulation for VTE.As of January 2013, 44,794 patients were enrolled in RIETE, of whom 7911 (18%) had active cancer. During the course of anticoagulant therapy (mean, 181 ± 210 days), 178 cancer patients (4.3%) developed recurrent PE (5.5 per 100 patient-years; 95% CI: 4.8-6.4), 194 (4.7%) had recurrent DVT (6.2 per 100 patient-years; 95% confidence interval [CI]: 5.3-7.1), and 367 (8.9%) bled (11.3 per 100 patient-years; 95% CI: 10.2-12.5). Of 4125 patients initially presenting with PE, 43 (1.0%) died of recurrent PE and 45 (1.1%) of bleeding; of 3786 patients with DVT, 19 (0.5%) died of PE, and 55 (1.3%) of bleeding. During the first 3 months of anticoagulation, there were 59 (1.4%) fatal PE recurrences and 77 (1.9%) fatal bleeds. Beyond the third month, there were 3 fatal PE recurrences and 23 fatal bleeds.In RIETE cancer patients, the rate of fatal recurrent PE or fatal bleeding was much higher within the first 3 months of anticoagulation therapy.

O papel atual da ultra-sonografia transretal da próstata na detecção precoce do câncer prostático

OBJETIVO: Determinar o papel real que a ultra-sonografia da próstata, notadamente com a associação do Doppler colorido, desempenha no diagnóstico de lesões malignas na próstata. MATERIAIS E MÉTODOS: Foram estudados, prospectivamente, 84 pacientes submetidos a biópsia guiada por ultra-sonografia transretal. Em todos os pacientes foram feitos estudo com Doppler colorido, à procura de focos de hipervascularização, e o exame ultra-sonográfico habitual. Os resultados foram comparados com os diagnósticos histopatológicos obtidos. RESULTADOS: A ultra-sonografia transretal habitual (escala de cinza) apresentou sensibilidade de 67,7%, especificidade de 52,8%, valor preditivo positivo de 45,6% e valor preditivo negativo de 73,6%. A adição do estudo com Doppler colorido ocasionou aumento importante da especificidade (de 52,8% para 79,2%) e do valor preditivo positivo (de 45,6% para 62,0%), porém causou queda na sensibilidade (de 67,7% para 58,0%). Além disso, houve perda de 32,2% dos cânceres, que não foram diagnosticados por nenhum dos dois métodos, e esses pacientes, apesar de possuírem cânceres menos extensos, eram todos clinicamente significativos (Gleason 6 ou mais). CONCLUSÃO: Mesmo com a associação do Doppler colorido, a ultra-sonografia transretal não possui capacidade suficiente para definir, através dos seus achados, quais pacientes devem ou não realizar biópsia.

Generic utilities in chronic obstructive pulmonary disease patients stratified according to different staging systems.

Background To determine generic utilities for Spanish chronic obstructive pulmonary disease (COPD) patients stratified by different classifications: GOLD 2007, GOLD 2013, GesEPOC 2012 and BODEx index. Methods Multicentre, observational, cross-sectional study. Patients were aged ≥40 years, with spirometrically confirmed COPD. Utility values were derived from EQ-5D-3 L. Means, standard deviations (SD), medians and interquartile ranges (IQR) were computed based on the different classifications. Differences in median utilities between groups were assessed by non-parametric tests. Results 346 patients were included, of which 85.5% were male with a mean age of 67.9 (SD = 9.7) years and a mean duration of COPD of 7.6 (SD = 5.8) years; 80.3% were ex-smokers and the mean smoking history was 54.2 (SD = 33.2) pack-years. Median utilities (IQR) by GOLD 2007 were 0.87 (0.22) for moderate; 0.80 (0.26) for severe and 0.67 (0.42) for very-severe patients (p < 0.001 for all comparisons). Median utilities by GOLD 2013 were group A: 1.0 (0.09); group B: 0.87 (0.13); group C: 1.0 (0.16); group D: 0.74 (0.29); comparisons were statistically significant (p < 0.001) except A vs C. Median utilities by GesEPOC phenotypes were 0.84 (0.33) for non exacerbator; 0.80 (0.26) for COPD-asthma overlap; 0.71 (0.62) for exacerbator with emphysema; 0.72 (0.57) for exacerbator with chronic bronchitis (p < 0.001). Comparisons between patients with or without exacerbations and between patients with COPD-asthma overlap and exacerbator with chronic bronchitis were statistically-significant (p < 0.001). Median utilities by BODEx index were: group 02: 0.89 (0.20); group 34: 0.80 (0.27); group 56: 0.67 (0.29); group 79: 0.41 (0.31). All comparisons were significant (p < 0.001) except between groups 34 and 56. Conclusion Irrespective of the classification used utilities were associated to disease severity. Some clinical phenotypes were associated with worse utilities, probably related to a higher frequency of exacerbations. GOLD 2007 guidelines and BODEx index better discriminated patients with a worse health status than GOLD 2013 guidelines, while GOLD 2013 guidelines were better able to identify a smaller group of patients with the best health.